Previous reports have shown that intestinal HTR3a and SERT were involved in the development of NAFLD in mice (Haub et al., 2010; Haub et al., 2011; Choi et al., 2018). The gene discussed is HTR3A; the disease is metabolic dysfunction-associated steatotic liver disease.